Independent & educational platform Not a government body. No link or affiliation with any government organisation. Made for learning only. Test only systems you own or are authorised to test. Become a Partner or Sponsor → Full disclaimer

CVE-2026-110240

medium

Lancet through 2.3.9 contains an SSRF protection bypass vulnerability in netutil.IsInternalIP that misclassifies IPv6 private, link-local, CGNAT and transition…

Lancet through 2.3.9 contains an SSRF protection bypass vulnerability in netutil.IsInternalIP that misclassifies IPv6 private, link-local, CGNAT and transition addresses as external. Attackers can supply hostnames resolving to these address forms, including NAT64, 6to4 or Teredo embedding internal IPv4, to reach internal services or cloud metadata endpoints.

CVSS
4.8
4.8 (CVSS v3.1)
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:N
Severity source: NVD CVSS v3.1 (disclosure@vulncheck.com)
Timeline (UTC)
Published: 2026-10-13 19:18
Modified: 2026-10-13 20:17
NVD status: Awaiting Analysis
Last synced 1 day ago
Verified against the source API 2026-10-27 06:59 UTC
Exploitation
Not listed in CISA KEV (as of last catalog sync)
Absence from KEV does not mean a CVE is not exploited. Exploitation status: unknown (no authoritative evidence in our sources).

Affected products

Not reported by the source (unknown — not "none").

Weakness classification (CWE)

CWE-918

Source: NVD / CISA. “NVD-CWE-Other” and “NVD-CWE-noinfo” mean NVD could not assign a specific weakness.

Mitigation & advisories

No vendor advisory or patch reference tagged by NVD. Check the references below.

References

Data sources

NVD CVE API 2.0 — fetched 2026-10-27 06:59 UTC · record ↗

Learn the basics

Understanding CVEs and CVSS Scores